As the results showed, the down-regulation of PTPRC increased the tumoral (MBA-MD-231) expression of PD-L1 about 1.53-fold as compared to NC group, while the expression level of tumor-derived IL2 was down-regulated (Figures 11H, I). This evidence concerns the gene IL2 and neoplasm.